The estimated Net Worth of Roger Adsett is at least $16.3 million dollars as of 17 May 2024. Mr. Adsett owns over 5,945 units of Insmed Inc stock worth over $10,861,249 and over the last 8 years he sold INSM stock worth over $1,671,456. In addition, he makes $3,728,400 as Chief Operating Officer at Insmed Inc.
Roger has made over 14 trades of the Insmed Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 5,945 units of INSM stock worth $149,160 on 17 May 2024.
The largest trade he's ever made was selling 11,855 units of Insmed Inc stock on 22 November 2022 worth over $222,874. On average, Roger trades about 2,614 units every 70 days since 2016. As of 17 May 2024 he still owns at least 149,275 units of Insmed Inc stock.
You can see the complete history of Mr. Adsett stock trades at the bottom of the page.
Roger Adsett serves as Chief Operating Officer of the Company., with effective 14 November 2019. Mr. Adsett joined Insmed as Chief Commercial Officer in September 2016 and was promoted to Chief Operating Officer in November 2019. Mr. Adsett has over 20 years of experience in the global biotechnology and pharmaceutical industry. From January 2015 to September 2016, Mr. Adsett was Senior Vice President, Head of Gastrointestinal and Internal Medicine Business Unit at Shire Plc (Shire), a global specialty biopharmaceutical company. From August 2008 to January 2015, Mr. Adsett was Senior Vice President, Gastrointestinal Business Unit Leader at Shire. From October 2005 to August 2008, Mr. Adsett was General Manager, Oral IBD Products of the Gastroenterology Business Unit of Shire. From November 1994 to October 2005, Mr. Adsett held various marketing and commercial roles at AstraZeneca plc, a multinational pharmaceutical and biopharmaceutical company. Mr. Adsett was a senior analyst at Accenture PLC, a global professional services company, from September 1991 to November 1994. Mr. Adsett holds a Masters of Business Administration from The Wharton School at the University of Pennsylvania and a Bachelor of Arts in English and Economics from Bucknell University.
As the Chief Operating Officer of Insmed Inc, the total compensation of Roger Adsett at Insmed Inc is $3,728,400. There are 1 executives at Insmed Inc getting paid more, with William Lewis having the highest compensation of $7,175,090.
Roger Adsett is 51, he's been the Chief Operating Officer of Insmed Inc since 2019. There are 17 older and 4 younger executives at Insmed Inc. The oldest executive at Insmed Inc is Steinar Engelsen, 70, who is the Independent Director.
Roger's mailing address filed with the SEC is 700 US HIGHWAY 202/206, , BRIDGEWATER, NJ, 08807.
Over the last 22 years, insiders at Insmed Inc have traded over $46,121,705 worth of Insmed Inc stock and bought 1,080,212 units worth $8,226,993 . The most active insiders traders include Llc Fmr, William Lewis et Dennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of $2,452,158. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth $407,689.
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Insmed Inc executives and other stock owners filed with the SEC include: